2019 IPO

TP Therapeutics Stock

TP Therapeutics is a structure-based drug design pharmaceutical company

Sign up today and learn more about TP Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About TP Therapeutics Stock

TP Therapeutics, Inc. is a structure-based drug design pharmaceutical company founded by Dr. J. Jean Cui, the lead inventor of Pfizer's Xalkori(TM) (generic name: crizotinib), the precision oncology drug for non-small cell lung cancer (NSCLC). Xalkori(TM) was approved by US Food and Drug Administration on August 26th, 2011.

Funding History

January 2014$1.4M
March 2016$18.0M
May 2017$45.0M
October 2018$80.0M


Founder & CSO

J. Jean Cui

Senior Vice President, Clinical Operations and Regulatory Affairs

John K.C. Lim


Athena Countouriotis

Co-founder, Chairman, President, and CEO

Y. Peter Li

Vice President of Pre-Clinical Development

Jeffrey P. Whitten

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: